Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2009-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2011-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2011524531-A |
titleOfInvention |
Drug safety test using pentraxin 3 (PTX3) |
abstract |
The present invention is an in vitro method for evaluating the immunogenicity of a compound of interest comprising: a) preparing a whole blood sample, wherein the blood is exposed to the compound of interest; b) pentraxin in the sample And c) comparing the measured level of pentraxin 3 with a control. |
priorityDate |
2008-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |